76 related articles for article (PubMed ID: 11706623)
1. Heterogeneity of p53 mutational status in the superficial spreading type of early gastric carcinoma.
Iwamatsu H; Nishikura K; Watanabe H; Ajioka Y; Hashidate H; Kashimura H; Asakura H
Gastric Cancer; 2001; 4(1):20-6. PubMed ID: 11706623
[TBL] [Abstract][Full Text] [Related]
2. Analysis of regional differences of p53 mutation in advanced gastric carcinoma: relation to heterogeneous differentiation and invasiveness.
Cho JH; Noguchi M; Ochiai A; Uchino S; Hirohashi S
Mod Pathol; 1994 Feb; 7(2):205-11. PubMed ID: 8008744
[TBL] [Abstract][Full Text] [Related]
3. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
4. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenesis of gastric endocrine cell carcinoma: analysis of histopathology and p53 gene alteration.
Nishikura K; Watanabe H; Iwafuchi M; Fujiwara T; Kojima K; Ajioka Y
Gastric Cancer; 2003; 6(4):203-9. PubMed ID: 14716513
[TBL] [Abstract][Full Text] [Related]
6. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.
Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y
Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362
[TBL] [Abstract][Full Text] [Related]
7. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
[TBL] [Abstract][Full Text] [Related]
8. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis.
Cho JH; Kim WH
Pathol Res Pract; 1998; 194(5):309-17. PubMed ID: 9651943
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between laminin and fibronectin on the basement membrane and tumor progression in early gastric cancer: an immunohistochemical study].
Fujita J
Hokkaido Igaku Zasshi; 2000 Jan; 75(1):25-34. PubMed ID: 10736758
[TBL] [Abstract][Full Text] [Related]
10. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
Pan W; Ishii H; Ebihara Y; Gobe G
J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
[TBL] [Abstract][Full Text] [Related]
11. p53 mutations and microsatellite instabilities in the subtype of intestinal metaplasia of the stomach.
Kim SS; Bhang CS; Min KO; Chae HS; Choi SW; Lee CD; Lim KW; Chung IS; Park DH
J Korean Med Sci; 2002 Aug; 17(4):490-6. PubMed ID: 12172044
[TBL] [Abstract][Full Text] [Related]
12. How wild-type TP53 is inactivated in undifferentiated-type gastric carcinomas: analyses of intratumoral heterogeneity in deletion and mutation of TP53.
Yoshimura A; Sugihara H; Ling ZQ; Peng DF; Mukaisho K; Fujiyama Y; Hattori T
Pathobiology; 2006; 73(1):40-9. PubMed ID: 16785766
[TBL] [Abstract][Full Text] [Related]
13. Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypes.
Oguri A; Ohmiya N; Taguchi A; Itoh A; Hirooka Y; Niwa Y; Maeda O; Ando T; Goto H
Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):561-6. PubMed ID: 17556902
[TBL] [Abstract][Full Text] [Related]
14. p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma.
Lim BH; Soong R; Grieu F; Robbins PD; House AK; Iacopetta BJ
Int J Cancer; 1996 Jun; 69(3):200-4. PubMed ID: 8682588
[TBL] [Abstract][Full Text] [Related]
15. p53, p16 and RB expression in adenosquamous and squamous cell carcinomas of the stomach.
Lee WA; Woo DK; Kim YI; Kim WH
Pathol Res Pract; 1999; 195(11):747-52. PubMed ID: 10605694
[TBL] [Abstract][Full Text] [Related]
16. [Mutations of the p53 suppressor gene in gastric adenocarcinoma].
Aranda M; Náquira N; Karque R; Mendoza H; Sepúlveda C; Silva C
Rev Med Chil; 1998 May; 126(5):525-32. PubMed ID: 9731434
[TBL] [Abstract][Full Text] [Related]
17. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
[TBL] [Abstract][Full Text] [Related]
18. Morphologic, histologic, and molecular similarities between adenocarcinomas arising in the gastric stump and the intact stomach.
Safatle-Ribeiro AV; Ribeiro Júnior U; Reynolds JC; Gama-Rodrigues JJ; Iriya K; Kim R; Bakker A; Swalsky PA; Pinotti HW; Finkelstein SD
Cancer; 1996 Dec; 78(11):2288-99. PubMed ID: 8940997
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of p53 mutational status in intramucosal carcinoma of the colorectum.
Yamada S; Ajioka Y; Watanabe H; Hashidate H; Takaku H; Kazama S; Yokoyama J; Nishikura K; Fujiwara T; Asakura H
Jpn J Cancer Res; 2001 Feb; 92(2):161-6. PubMed ID: 11223545
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach.
Semba S; Yokozaki H; Yamamoto S; Yasui W; Tahara E
Cancer; 1996 Apr; 77(8 Suppl):1620-7. PubMed ID: 8608553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
